Abstract
Get full access to this article
View all access options for this article.
References
1.
2.Genetics Home Reference (2015) Bloom syndrome . Available at http://ghr.nlm.nih.gov/condition/bloom-syndrome, accessed March 24 , 2015
3.
Gutierrez
A
(2013 ) Warning letter . Available at www.fda.gov/iceci/enforcementactions/warningletters/2013/ucm376296.htm, accessed March 25 , 2015
4.
Obama
B
. (January 2015). President Obama Speaks on the Precision Medicine Initiative. Speech presented at The White House , Washington, DC . Available at https://www.whitehouse.gov/photos-and-video/video/2015/01/30/president-obama-speaks-precision-medicine-initiative
5.
Terry
SF
(2015 ) Participating in next generation sequencing . Genet Test Mol Biomarkers , 19 :174 .
6.U.S. Food and Drug Administration (2014) Regulatory controls . Available at www.fda.gov/medicaldevices/deviceregulationandguidance/overview/generalandspecialcontrols/default.htm, accessed March 21 , 2015
7.U.S. Food and Drug Administration (2015) FDA permits marketing of first direct-to-consumer genetic carrier test for Bloom syndrome . Available at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm435003.htm, accessed March 20 , 2015
8.The White House (2015) Fact Sheet : President Obama's Precision Medicine Initiative . Available at www.whitehouse.gov/the-press-office/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative, accessed March 24 , 2015
9.
Wojcicki
A
(2015 ) A note to our customers regarding the FDA . Available at http://blog.23andme.com/news/a-note-to-our-customers-regarding-the-fda/, accessed March 22 , 2015